Site References


Publications & Guidelines

  1. American Diabetes Association. 2018. Glycemic Targets: Standards of Medical Care in Diabetes—2018. Diabetes Care. 41(Supplement 1):S55-S64.
  2. Bergenstal R, Peyrot M, Dreon D, Aroda V, Bailey T, Brazg R, Frias J, Johnson M, Klonoff D, Kruger D, Ramtoola S, Rosenstock J, Serusclat P, Weinstock R, Naik R, Shearer D, Zraick V, Levy B on behalf of the Calibra Study Group. 2019. Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with and Insulin Pen. Diabetes Technology and Therapeutics 21 (5):1-13.
  3. Bohannon N, Bergenstal R, Cuddihy R, Kruger D, List S, Massaro E, Molich M, Raskin P, Remtema H, Strowig S, Whitehouse F, Brunelle R, Dreon D, Tan M. 2011. Comparison of a Novel Insulin Bolus-Patch with Pen/Syringe Injection to Deliver Mealtime Insulin for Efficacy, Preference, and Quality of Life in Adults with Diabetes: A Randomized, Crossover, Multicenter Study. Diabetes Technology & Therapeutics. 13(10):1031-1037.
  4. Chase HP, Horner B, McFann K, Yetzer H, Gaston J, Banion C, Fiallo-Scharer R, Slover R, Klingensmith G. 2010. The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control. Diabetes Care. 29(5):1012-1015.
  5. Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. 2013. Real-world Factors Affecting Adherence to Insulin Therapy in Patients with Type 1 Or Type 2 Diabetes Mellitus: A Systematic Review. Diabetic Medicine., 30(5):512-524.
  6. Dreon D, Hannon T, Cross B, Carter B, Mercer N, Nguyen J, Tran A , Melendez P, Morales N, Nelson J, Tan M. 2018. Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System. Journal of Diabetes Science and Technology. 12(4):817-827.
  7. Hermanns N, Lilly L, Mader JK, Aberer F, Ribitsch A, Kojzar H, Warner J, Pieber T. 2015. Novel Simple Insulin Delivery Device Reduces Barriers to Insulin Therapy in Type 2 Diabetes: Results From a Pilot Study. J Diabetes Sci Technol. 9(3):581-587.
  8. Hirsch IB, Bergenstal RM, Parkin CG, Wright E Jr., Buse JB. 2005. A Real-World Approach to Insulin Therapy in Primary Care Practice. Clinical Diabetes. 23(2):78-86.
  9. Lilly L, Mader JK, Warner J. 2018. Developing a Simple 3-Day Insulin Delivery Device to Meet the Needs of People With Type 2 Diabetes. Journal of Diabetes Science and Technology. 13(1):11-19.
  10. Mader JK, Lilly L, Aberer F, Korsatko S, Strock E, Mazze R, Damsbo P, Pieber T. 2014. A Feasibility Study of a 3-Day Basal-Bolus Insulin Delivery Device in Individuals With Type 2 Diabetes. Diabetes Care. 37(5):1476-1479.
  11. Mader JK, Lilly L, Aberer F, Poettler T, Johns D, Trautmann M, Warner J, Pieber T. 2018. Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes. Diabetic Medicine. 35(10):1448–1456.
  12. Peyrot M, Rubin R, Kruger D, Travis L. 2010. Correlates of Insulin Injection Omission. Diabetes Care. 33(2):240–245.
  13. Peyrot M, Bailey T, Childs B, Reach G. 2018. Strategies for implementing effective mealtime insulin therapy in type 2 diabetes. Current Medical Research and Opinion. 34(6):1153-1162.
  14. Peyrot M, Barnett A, Meneghini L, Schumm‐Draegeral P. 2012. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy Study. Diabetic Medicine. 29:682–689.
  15. Peyrot M, Dreon D, Zraick V, Cross B, Tan MH. 2018. Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch. Diabetes Therapy. 9(1):297–307.
  16. Randløv J, Poulsen JU. 2008. How Much Do Forgotten Insulin Injections Matter to Hemoglobin A1c in People with Diabetes? A Simulation Study. Journal of Diabetes Science and Technology. 2(2):229–235.
  17. Selvin E,Parrinello CM, Daya N, Bergenstal RM. 2016. Trends in Insulin Use and Diabetes Control in the U.S.;1988-1994 and 1999-2012. Diabetes Care. 39(3):e33-e35.
  18. Wahlqvist P, Warner J, Morlock R. 2018. Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model. Journal of Health Economics and Outcomes Research. 6(1):84-95.
  19. Wright A, Burden ACF, Paisey RB, Cull CA, Holman RR, and the UK Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care. 2002;25: 330-336.

Posters & Data

  1. Zraick V, Dreon D, Nalk R, Shearer D, Crawford S, Bradford J, Levy B. 2016. Patient User Experience Evaluation of Bolus Patch Insulin Delivery System. Poster presented at the American Diabetes Association’s 76th Scientific Sessions. Abstract 995-P. New Orleans, LA, USA.
  2. Health Advances LLC. 2017 Simple Infusion Device Market Model., Health Advances interviews and analysis. Confidential–Not for Distribution Without Permission from CeQur SA and Health Advances LLC.